Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: Compare the efficacy of 3 weekly Intralesional triamcinolone injection versus intralesional vitamin D3 injection in keloids at the end of 12 weeks: Injection Vitamin D3(cholecalciferol)
Sponsors
SIKSHA O ANUSANDHAN UNIVERSITY
Eligibility
Inclusion criteria
Inclusion criteria: : 1. All patients with keloids above 18 years of age. 2. patients having two or more than two keloids not more than 5cm 3. No treatment done for keloids in last 6 months
Exclusion criteria
Exclusion criteria: 1. Pregnancy and lactation 2. Family history of keloids. 3. Diabetes mellitus. 4.keloids on face
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesions will be assessed by clinical examination, Vancouver Scar Scale (VSS), digital photograph and Visual Analogue Scale for pain during treatment. Timepoint: Assessment will be done at baseline and every 3 weeks and 1 month after last dose. | — |
Secondary
| Measure | Time frame |
|---|---|
| The clinical improvement will be defined as decreasing values of the scores and complete recovery as scores reach to zero.Timepoint: Scar flattening will be consired as 1mm scar height over 90% of the lesion | — |
Countries
India
Contacts
Public ContactDr Nibedita Dixit
Ims and Sum Hospital
Outcome results
None listed